Literature DB >> 11179252

Who should take aspirin for primary prophylaxis of coronary heart disease?

G D Lowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11179252      PMCID： PMC1729669          DOI： 10.1136/heart.85.3.245

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  2 in total

Review 1.  Measurement of thrombosis and its prevention.

Authors:  Gordon D O Lowe
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Authors:  Jill Belch; Angus MacCuish; Iain Campbell; Stuart Cobbe; Roy Taylor; Robin Prescott; Robert Lee; Jean Bancroft; Shirley MacEwan; James Shepherd; Peter Macfarlane; Andrew Morris; Roland Jung; Christopher Kelly; Alan Connacher; Norman Peden; Andrew Jamieson; David Matthews; Graeme Leese; John McKnight; Iain O'Brien; Colin Semple; John Petrie; Derek Gordon; Stuart Pringle; Ron MacWalter
Journal:  BMJ       Date:  2008-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.